Sanofi to pay Regeneron US$462 million in revised immuno-oncology deal

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Sanofi will pay Regeneron some US$462 million in a revision of their deal in immuno-oncology, a growing sector in healthcare research which aims ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA advisory panel split over Sanofi-Lexicon diabetes drugREUTERS: An advisory panel to the U.S. Food and Drug Administration was divided over whether to recommend approval of a treatment for type 1 ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »